eTRANSAFE: data science to empower translational safety assessment

Sanz, F, Pognan, F, Steger-Hartmann, T, Diaz, C, Asakura, S, Amberg, A, Bécourt-Lhote,, N, Blomberg,, N, Bosc, N, Briggs, K, Bringezu, F, Brulle-Wohlhueter,, C, Brunak, S, Bueters, R, Callegaro, G, Capella-Gutierrez,, S, Centeno, E, Corvi, J, Cronin, M, Drew, P et al (2023) eTRANSAFE: data science to empower translational safety assessment. Nature Reviews Drug Discovery. ISSN 1474-1776

[thumbnail of NRDD eTRANSAFE comment clean 2505.pdf]
Preview
Text
NRDD eTRANSAFE comment clean 2505.pdf - Accepted Version

Download (298kB) | Preview
Open Access URL: https://www.nature.com/articles/d41573-023-00099-5 (Accepted version)

Abstract

Thirteen pharmaceutical companies have shared and integrated preclinical and clinical data for creating computational resources that enhance translational drug safety assessment.

Item Type: Article
Uncontrolled Keywords: 06 Biological Sciences; 11 Medical and Health Sciences; Pharmacology & Pharmacy
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy and Biomolecular Sciences
Publisher: Nature Research
Date of acceptance: 14 June 2023
Date of first compliant Open Access: 14 December 2023
Date Deposited: 15 Jun 2023 10:08
Last Modified: 14 Dec 2023 00:50
DOI or ID number: 10.1038/d41573-023-00099-5
URI: https://ljmu-9.eprints-hosting.org/id/eprint/19820
View Item View Item